Daxor Corporation Common Stock vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| DXR | RMD | |
|---|---|---|
| Market Cap | $66.85 million | $32.34 billion |
| Revenue (TTM) | $1.45 million | — |
| Net Income (TTM) | $-7,185,639 | — |
RMD leads on 1 of 1 size & scale factors.
Valuation
| DXR | RMD | |
|---|---|---|
| Price / Book | 1.85 | — |
| Price / Sales | 46.22 | — |
DXR and RMD split the valuation factors evenly.
Profitability
| DXR | RMD | |
|---|---|---|
| Net Margin | -496.81% | — |
| Return on Equity | -19.84% | — |
DXR and RMD split the profitability factors evenly.
Dividend
| DXR | RMD | |
|---|---|---|
| Dividend Yield | 0.26% | 1.15% |
RMD leads on 1 of 1 dividend factors.
Risk & Sentiment
| DXR | RMD | |
|---|---|---|
| Short Interest | 0.00% | 4.14% |
DXR leads on 1 of 1 risk & sentiment factors.
Dig deeper: DXR overview, DXR financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.